KATHRYN HOOK: Open Payments
NPI 1528450343 · ANTIOCH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 55 payments from 13 companies in 2025. Trend: 2023 $991 · 2024 $906 · 2025 $1,191
Food & beverage: $1,058Education: $133
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $275 |
| GENZYME CORPORATION | 12 | $191 |
| GlaxoSmithKline, LLC. | 7 | $169 |
| ARS Pharmaceuticals Operations, Inc. | 7 | $167 |
| AstraZeneca Pharmaceuticals LP | 3 | $84 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Genentech USA, Inc. | 3 | $72 |
| Amgen Inc. | 3 | $62 |
| CSL Behring | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
Products named: DUPIXENT, NEFFY, NUCALA, TEZSPIRE, TRELEGY ELLIPTA, Xolair, AYVAKIT, Rhapsido.
Industry payments across CA — which companies pay providers there.
